Technical brief | 07 April 2023 Pandemic preparedness Intellectual property and trade Pandemic Accord: MSF’s Comments on Equity Provisions in Zero Draft
Technical brief | 02 February 2023 HIV/AIDS Agents of Change: Long-acting Formulations for Prevention and Treatment of HIV
Technical brief | 11 November 2022 Transparency Research and development MSF Clinical Trial Transparency Policy
Issue brief Issue brief | 08 November 2022 Tuberculosis DR-TB Drugs Under the Microscope, 8th Edition
Technical brief | 02 November 2022 Intellectual property and trade Damaging provisions for access to medicines in the UK-India FTA negotiation text
Technical brief | 17 October 2022 Research and development Roundtable: How Can Disclosing Clinical Trial Costs Increase Access to Medical Products?
Technical brief | 13 September 2022 Diagnostics Africa-South Korea Roundtable: Working Together on Local Production of Diagnostics
Technical brief | 01 August 2022 Intellectual property and trade The importance of pre-grant patent oppositions in increasing access to medical products
